The story of Sildenafil presents a intricate picture for investors. While the initial introduction generated significant profits, the end of its intellectual property protection opened the door to cheaper alternatives, https://bookmarkworm.com/story21577342/the-copyright-and-the-pharmaceutical-industry-a-risky-bet